Listen
In this episode, host Alyssa Watson, DVM, talks with Michaela Beasley, DVM, MS, MBA, CCRP, DACVIM (Neurology), about her recent Clinician’s Brief article, “Seizure Management in a Fractious Dog.” Dr. Beasley discusses the complexities of seizure management in dogs, particularly those exhibiting fearful or aggressive behavior. She reviews the case of Bully, a young Labrador with idiopathic epilepsy, exploring his diagnosis, treatment options, and the rationale behind choosing specific anticonvulsants. Dr. Beasley covers the importance of monitoring medication effects, potential side effects, and the role of diet and ancillary therapies in managing seizures.
Watch
Key Takeaways
Seizure management in dogs requires careful consideration of behavior as some anticonvulsants cause polyphagia and increased risk of food aggression.
Levetiracetam is a reasonable first-line anticonvulsant for patients that are fearful or reactive in the clinic setting due to its minimal monitoring requirements.
Regular monitoring of liver values is crucial when using zonisamide in dogs, as there is a risk of irreversible hepatotoxicity.
Dogs receiving potassium bromide treatment may experience hypertriglyceridemia, which can increase their risk of developing pancreatitis.
Administering previsit medications can help reduce anxiety in dogs during veterinary appointments and is generally considered safe for those receiving anticonvulsants.
Contact:
Where To Find Us:
Website: CliniciansBrief.com/Podcasts
YouTube: Youtube.com/@clinicians_brief
Facebook: Facebook.com/CliniciansBrief
LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
Instagram: @Clinicians.Brief
The Team:
Alyssa Watson, DVM - Host
Alexis Ussery - Producer & Multimedia Specialist